Supermarket/Hypermarket Opportunistic Screening for Atrial Fibrillation (SHOPS-AF): A Mixed Methods Feasibility Study

Ian D Jones1,2, Deirdre A Lane2,3,4, Robyn R Lotto1,2

  • 1School of Nursing and Allied Health, Faculty of Health, Liverpool John Moores University, Liverpool L3 2AJ, UK.

Insights

This study tested a novel approach to screen for atrial fibrillation (AF) using a hand-held electrocardiogram (ECG) device embedded in supermarket trolleys. The feasibility of this method for widespread AF detection will inform future large-scale trials.

Area of Science:

  • Cardiology
  • Public Health
  • Medical Technology

Background:

  • Atrial fibrillation (AF) is a common heart arrhythmia and a major risk factor for ischemic stroke.
  • Oral anticoagulation significantly reduces stroke risk in AF patients.
  • Hand-held electrocardiogram (ECG) devices offer potential for routine AF screening.

Purpose of the Study:

  • To evaluate the effectiveness of a hand-held ECG sensor (MyDiagnostick) for AF screening when integrated into supermarket trolley handles.
  • To assess the feasibility of embedding AF detection technology into everyday objects for opportunistic screening.

Main Methods:

  • A mixed-methods approach involving a two-phase study.
  • Phase 1: Quantitative assessment with 2000 participants using MyDiagnostick-equipped trolleys in supermarkets.
  • Phase 2: Qualitative interviews with pharmacists and store managers to explore staff perceptions.

Main Results:

  • The study will determine the sensitivity, specificity, and predictive values of the MyDiagnostick sensor for AF detection.
  • Data will be collected on participant engagement and the practicalities of in-store screening.
  • Pharmacist and manager feedback will provide insights into the implementation of this screening strategy.

Conclusions:

  • This feasibility study is designed to inform a larger, definitive trial on AF screening using integrated technology.
  • The findings will guide the development of innovative, routine screening programs for atrial fibrillation.
Abstract